AI News
 Pfizer’s Migraine Drug Approval Triggers $475M Payment to Royalty Pharma
MedCity News - (Friday March 17, 2023) FDA approval of Pfizer nasal spray migraine drug Zavzpret last week means a $475 million payday for Royalty Pharma. The payment stems from a financing deal Pfizer inherited when it acquired rights to the…  FDA Commissioner: Insurers Need To Support Studies In Accelerated Drug Approval Pathway
MedCity News - (Friday March 17, 2023) The Food and Drug Administration’s Dr. Robert Califf called on insurers Thursday to help ensure that studies on new drugs in the accelerated approval pathway are still completed. |
  Accenture: Data Collaboratives Hold Great Promise for Accelerated Healthcare Progress and Precision Medicine
HIT Consultant - (Thursday March 16, 2023) What You Should Know:– Accenture published Fast-Forwarding Healthcare through Data Collaboratives Report to discover how best health ecosystem players access data to fast-forward healthcare.– Data generated by technical and scientific advances, like connected health… |
 Register Now for INVEST and Be Part of the Conversation on Violence Against Healthcare Workers
MedCity News - (Thursday March 16, 2023) At the MedCity INVEST conference at the Ritz Carlton in Chicago May 22-24, a panel will focus on violence against healthcare professionals. It’s an unfortunate trend that is on the rise, spurred by misinformation…  ObvioHealth Launches Decentralized Clinical Trial for Migraine Treatment Device
HIT Consultant - (Thursday March 16, 2023) What You Should Know:– ObvioHealth and Mi-Helper, Inc. announce a partnership to conduct a decentralized clinical trial for a non-invasive neuromodulation device for the treatment of migraines. The randomized controlled trial will be fully remote,… |
 KLAS: State of Small-Hospital Patient Accounting 2023
HIT Consultant - (Thursday March 16, 2023) What You Should Know:– Small hospitals are changing their EMRs and patient accounting systems at a greater rate than that of their large-hospital counterparts. Most market selection energy is going to Oracle Health (Cerner),…  Solution to Clinical Trial Enrollment Lies Hidden in FDA Guidance
MedCity News - (Thursday March 16, 2023) New medications take too long to get into the hands of people who need them – a decade, on average. The leading cause of delays is finding patients for clinical trials, but it shouldn’t… |
 Pill Vaccine Biotech Vaxart Suspends Covid-19 Trial, Keeps Norovirus Focus
MedCity News - (Thursday March 16, 2023) Vaccine developer Vaxart contends its pill vaccinations against Covid-19 will be preferable to patients, and potentially more effective than currently available injections. But a different virus offers the biotech a clearer and faster path…  Almost Half of Health Systems Use AI for Workforce Issues
Health IT Analytics - (Thursday March 16, 2023) By Mark Melchionna |
